Back to all presentations
Redeye interview with CEO Kristina Torfgård
Alzinova's CEO Kristina Torfgård was interviewed on February 26, 2021 by Redeye’s Life Science analyst Anders Hedlund.
In this interview, Kristina talks about highlights from Alzinova’s year-end report 2020, the upcoming clinical study with therapeutic vaccine, ALZ-101 and summarizes her first year as CEO for Alzinova.
Click the image below to see the interview (in Swedish).
